Follow The Filings

ORI Old Rep International Corporation

Financials, filed as OLD REP INTL CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $11M
  • 1 small

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.02%

Who owns ORI

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.02% Small add +3.8% 277,779 $11M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ORI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ORI insider trades
  • $100K bought by 2 insiders
  • $2.5M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Carolyn Monroe SVP - Title Insurance
    Sale
    $184K 4,386 shares at $42.01 14% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  2. Carolyn Monroe SVP - Title Insurance
    Sale
    $76K 1,788 shares at $42.26 5.3% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  3. Jeffrey Lange SVPUnderwriting & Distribution
    Sale
    $616K 14,075 shares at $43.76 54% of stake
    Traded Jul 29 Filed Jul 31
    ↗
  4. Stephen J Oberst Executive Vice President
    Sale
    $577K 13,125 shares at $43.96 14% of stake
    Traded Jul 28 Filed Jul 30
    ↗
  5. Carolyn Monroe SVP - Title Insurance
    Sale
    $517K 13,330 shares at $38.76 29% of stake
    Traded May 12 Filed May 14
    ↗
  6. Therace Risch Director
    Buy
    $12K 300 shares at $39.90 +2.4% to stake
    Traded May 1 Filed May 5
    ↗
  7. John Eric Smith Director
    Buy
    $49K 1,135 shares at $43.10 +36% to stake
    Traded Mar 2 Filed Mar 4
    ↗
  8. Carolyn Monroe SVP - Title Insurance
    Sale
    $217K 5,526 shares at $39.28 17% of stake
    Traded Feb 2 Filed Feb 4
    ↗
  9. Carolyn Monroe SVP - Title Insurance
    Sale
    $298K 6,680 shares at $44.54 19% of stake
    Traded Nov 14, 2025 Filed Nov 18, 2025
    ↗
  10. Therace Risch Director
    Buy
    $39K 1,000 shares at $39.14 +10% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 share withholdings for taxes, 26 option exercises, 12 stock grants, and 3 gifts.

Congress

1 member of Congress traded ORI in the last three years: 0 buys and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Jefferson Shreve R-IN-6 Sell $15K–$50K May 12, 2025 filed Jun 22, 2025

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
424B3 PROSPECTUS Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 15 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $7.26B $8.23B $9.14B
Net income $598.6M $852.7M $935.4M
Net margin * 8.2% 10.4% 10.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $26.5B $27.84B $29.86B
Total equity $6.41B $5.62B $5.91B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.88B $1.23B $1.16B
Cash from investing $25.3M -$3.9M -$177.2M
Cash from financing -$0.783B -$1.23B -$0.926B
Net change in cash $122.5M $2.4M $61.3M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.